Association of Physical Function and Survival in Older-Adult Renal Transplant Recipients.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 26 03 2020
revised: 19 08 2020
accepted: 25 08 2020
pubmed: 27 9 2020
medline: 9 6 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

There is an increase in older-adult renal transplant recipients in United States. The objective of this study was to assess the association between physical function (PF) and patient survival in renal transplant recipients who are aged 65 years or older. Using United Network for Organ Sharing (UNOS) data from 2007 to 2016, renal transplant recipients aged 65 years or older were included. Multivariable Cox regression was used to assess associations between survival and functional status adjusted for age, sex, race, donor quality, diabetes, and dialysis vintage. The study identified 26,721 patients. Patient survival was significantly higher in recipients who needed no assistance and lowest in patients in need of total assistance (P < .0001). In deceased donor (DD) transplants, the relative risk for mortality was 2.06 (1.74-2.43) for total assistance and 1.17 (1.08-1.28) for moderate assistance compared to no assistance (P < .0001). In living donor (LD) transplants, the relative risk of mortality was 1.38 (0.78-2.42) for patients needing total assistance and 1.37 (1.14-1.65) for patients needing moderate assistance compared to patients who did not need assistance (0.003). PF is an independent predictor of post-transplant mortality. Assessment of older potential renal transplant recipients should include assessment and standardization of functional status to counsel about post-transplant survival.

Identifiants

pubmed: 32977978
pii: S0041-1345(20)30592-3
doi: 10.1016/j.transproceed.2020.08.038
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

913-919

Subventions

Organisme : NIMHD NIH HHS
ID : P20 MD006875
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Amarpali Brar (A)

University of California, San Francisco, California. Electronic address: amarpali.brar@ucsf.edu.

Angelika Gruessner (A)

SUNY Downstate School of Medicine, Brooklyn, New York.

Deborah Adey (D)

University of California, San Francisco, California.

Fasika Tedla (F)

Mount Sinai School of Medicine, New York, New York.

Ernie Yap (E)

SUNY Downstate School of Medicine, Brooklyn, New York.

Dheeraj Kaul (D)

SUNY Downstate School of Medicine, Brooklyn, New York.

Nabil Sumrani (N)

SUNY Downstate School of Medicine, Brooklyn, New York.

Devon John (D)

Westchester Medical Center, Valhalla, New York.

Moro O Salifu (MO)

SUNY Downstate School of Medicine, Brooklyn, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH